Amended Current Report Filing (8-k/a)
December 18 2020 - 6:05AM
Edgar (US Regulatory)
0001725255
true
0001725255
2020-06-18
2020-06-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No.1)
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): June 18, 2020
AdaptHealth
Corp.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-38399
|
|
82-3677704
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
220 West Germantown Pike, Suite 250
Plymouth Meeting, PA
|
|
19462
|
(Address of
principal executive offices)
|
|
(Zip Code)
|
(610)
630-6357
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed
since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Class A
Common Stock, par value $0.0001 per share
|
|
AHCO
|
|
The
Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
EXPLANATORY NOTE
AdaptHealth
Corp. is filing this Amendment No. 1 on Form
8-K/A to the Form 8-K originally filed June 18, 2020 (the “Original Filing”) solely to file a consent from
the independent auditor, RSM US LLP, which was not included in the Original Filing. This
Form 8-K/A does not modify, amend or update in any way any of the financial or other information contained in the Original
Filing. This Form 8-K/A does not reflect events that may have occurred subsequent to the filing date of the Original
Filing.
Item 9.01. Financial Statements and Exhibits
(a) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
Dated: December 18, 2020
|
AdaptHealth Corp.
|
|
|
|
By:
|
/s/ Jason Clemens
|
|
|
Name: Jason Clemens
|
|
|
Title: Chief Financial Officer
|
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Apr 2023 to Apr 2024